Chimeric receptors as gene switches

Current Opinion in Biotechnology

Volumn 8, Issue 4, 1997, Pages 474-479

  Allgood, Victoria E ^a   Eastman, Eric M ^b  

^a GeneMedicine Inc   (United States)

^b Gene Logic Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; CHIMERIC PROTEIN; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; STEROID RECEPTOR;

CELL DIFFERENTIATION; CELL MATURATION; EUKARYOTIC CELL; GENE CONTROL; GENE EXPRESSION REGULATION; GENE SWITCHING; GENE THERAPY; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; SHORT SURVEY; SIGNAL TRANSDUCTION;

EUKARYOTA;

EID: 0030854745     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0958-1669(97)80071-7     Document Type: Article

References (24)

1. Yarranton GT: Inducible vectors for expression in mammalian cells. Curr Opin Biotechnol 1992, 3:506-511.
2. Gossen M, Bonin AL, Bujard H: Control of gene activity in higher eukaryotic cells by prokaryotic regulatory elements. Trends Biochem Sci 1993, 18:471-475.
3. Crabtree GR, Schreiber SL: Three-part inventions: intracellular signaling and induced proximity. Trends Biochem Sci 1996, 21:418-422. An excellent summary of intracellular signaling by immunosuppressive drugs. This review discusses how these drugs act as chemical inducers of dimerization and the role of induced proximity in signal transduction.
4. Shockett P, Schatz D: Switching on gene expression. Nat Biotechnol 1997, 15:219-220.
5. Shockett PE, Schatz DG: Diverse strategies for tetracycline-regulated inducible gene expression. Proc Natl Acad Sci USA 1996, 93:5173-5176.
6. Allgood VE, Eastman EM: Novel gene switches for use in controlled regulation of gene expression. Annu Rev Med Chem 1997, in press. A recent review of drug-activated gene switches based on chimeric bacterial repressor proteins and chimeric eukaryotic intracellular receptors.
7. Ho SN, Biggar SR, Spencer DM, Schreiber SL, Crabtree GR: Dimeric ligands define a role for transcriptional activation domains in reinitiation. Nature 1996, 382:822-826. This paper describes the development of synthetic ligands capable of regulating transcription by controlling the association of separate DNA-binding and transactivation domains contained in chimeric proteins. Synthetic ligands are described that induce either homodimers or heterodimers.
8. Belshaw PJ, Ho SN, Crabtree GR, Schreiber SL: Controlling protein association and subcellular localization with a synthetic ligand that induces heterodimerization of proteins. Proc Natl Acad Sci USA 1996, 93:4604-4607. This paper describes the development of a bifunctional synthetic ligand that specifically induces the heterodimerization of chimeric proteins. Ligands and chimeric proteins are described that act at various steps in the processes of signal transduction and transcriptional regulation.
9. Rivera VM, Clackson T, Nateson S, Pollock R, Amara JP, Keenan T, Magari SR, Phillips T, Courage NL, Cerasoli F Jr et al.: A humanized system for pharmacologic control of gene expression. Nat Med 1996, 2:1028-1032. This paper demonstrates the use of rapamycin to regulate the gene expression in an ex vivo animal system. Rapamycin acts by inducing the heterodimerization of two chimeric proteins, derived totally from human proteins, to produce a functional transcriptional activator.
10. Carson-Jurica MA, Schrader WT O'Malley BW: Steroid receptor family: structure and functions. Endocr Rev 1990, 11:201-220.
11. Tsai M-J, O'Malley BW: Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 1994, 63:451-486.
12. Beato M, Herrlich P, Schultz G: Steroid hormone receptors: many actors in search of a plot. Cell 1995, 83:851-857.
13. Smith DF: Steroid receptors and molecular chaperones. Sci Am Sci Med 1995, July/August:38-47.
14. Green S, Chambon P: Oestradiol induction of a glucocorticoid-responsive gene by a chimaeric receptor. Nature 1987, 325:75-78.
15. No D, Yao T-P, Evans RM: Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc Natl Acad Sci USA 1996, 93:3346-3351. This paper describes the development of a gene switch based on a chimeric Drosophila EcR. For maximum activity, the chimeric receptor must be coexpressed with a member of the RXR family. Inductions as high as 20,000-fold were reported. Tissue-specific expression of the gene switch and drug-dependent target gene regulation were also demonstrated in transgenic mice.
16. Yao T-P, Segraves WA, Oro AE, McKeown M, Evans RM: Drosophila ultraspiracle modulates ecdysone receptor function via heterodimer formation. Cell 1992, 71:63-72.
17. Yao T-P, Forman BM, Jiang Z, Cherbas L, Chen J-D, McKeown M, Cherbas P, Evans RM: Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Nature 1993, 366:476-479.
18. Christopherson KS, Mark MR, Bajaj V, Godowski PJ: Ecdysteroid-dependent regulation of genes in mammalian cells by a Drosophila ecdysone receptor and chimeric transactivators. Proc Natl Acad Sci USA 1992, 89:6314-6318.
19. Whelan J, Miller N: Generation of estrogen receptor mutants with altered ligand specificity for use in establishing a regulatable gene expression system. J Steroid Biochem Mol Biol 1996, 58:312.
20. Wang Y, O'Malley BW Jr, Tsai SY, O'Malley BW: A regulatory system for use in gene transfer. Proc Natl Acad Sci USA 1994, 91:8180-8184.
21. Vegeto E, Allan GF, Schrader WT, Tsai M-J, McDonnell DP, O'Malley BW: The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor. Cell 1992, 69:703-713.
22. Delort JP, Capecchi MR: TAXI/UAS: a molecular switch to control expression of genes in vivo. Hum Gene Ther 1996, 7:809-820.
23. Wang Y, DeMayo FJ, Tsai SY, O'Malley BW: Ligand-inducible and liver-specific target gene expression in transgenic mice. Nat Biotechnol 1997, 15:239-243. Liver-specific expression of an antiprogestin-regulated gene switch and ligand-dependent expression of hGH was demonstrated in transgenic mice. Serum levels of hGH were induced as much as 33,000-fold, leading to significant weight gains in treated mice, demonstrating biological activity.
24. Wang Y, Xu J, O'Malley BW, Tsai SY: Positive and negative regulation of gene expression in eukaryotic cells with an inducible transcriptional regulator. Gene Ther 1997, 4: in press. This paper describes a number of significant improvements in the antiprogestin-activated gene switch as well as a ligand-dependent transcriptional repressor. Modifications in the length of the LBD and the position of the major transactivation domain generated a significantly more potent ligand-dependent transcriptional activator and a 10-fold reduction in threshold concentration for the ligand.